If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Mounjaro ® (tirzepatide) injection
2.5 mg/5 mg/7.5 mg/10 mg/12.5 mg/15 mg
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
Can Mounjaro® (tirzepatide) be used in people who have had surgery for weight loss?
Tirzepatide has not been studied in people who have undergone any type of bariatric surgery.
See important safety information, including boxed warning, in the attached prescribing information.
Weight Loss Surgeries
There is no information on the use of tirzepatide in people who have undergone any type of bariatric surgery. Patients were excluded from tirzepatide clinical trials if they had prior or planned bariatric surgery (ie, sleeve gastrectomy, gastric bypass, or gastric band (Lap-Band®).1
Enclosed Prescribing Information
Reference
1Data on file, Eli Lilly and Company and/or one of its subsidiaries.
Date of Last Review: February 21, 2023